TerminatedPhase 3NCT02770729
Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
Studying Acute endophthalmitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Campinas, Brazil
- Principal Investigator
- Mathias V Mélega, MDUniversity of Campinas
- Intervention
- Moxifloxacin(drug)
- Enrollment
- 3640 enrolled
- Eligibility
- 40-110 years · All sexes
- Timeline
- 2017 – 2018
Study locations (1)
- Mathias Violante Mélega, Campinas, São Paulo, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02770729 on ClinicalTrials.gov